Praxis Precision Medicines

Praxis Precision Medicines Employees

9 people indexed:

Alex Nemiroff

General Counsel

2594qu448@24q2936tgk01q14.7qz Sign up to see email

tjzlzlv35@wt7y46bkv4924t3.88l Sign up to see email
Alyssa Wyant

Chief Regulatory & Quality Officer

4gh60u@v2f1qhvjbh9lk0k.j7v Sign up to see email

h800k7@l7756637h6g3934.b05 Sign up to see email
Brian Spar

Chief of Staff

vflgq@jzwqhu8jkvu9394.1kz Sign up to see email

wz2jv@2h8u02t54861ttz.z66 Sign up to see email
Karl Hansen

Chief Technical Operations Officer

7fgwg9b@qz55q2ww63j1gut.2ty Sign up to see email

bb0t7wb@9ywgg4yzq1lv7jj.tl2 Sign up to see email
Kelly McCue

Chief People Officer

zvqy53@2tzjfgf219v1yy4.vzl Sign up to see email

by3gh4@47053hvbf1ly8h1.z02 Sign up to see email
Marcio Souza

President & Chief Executive Officer

q312h1@wgb679k1qg99tjt.t20 Sign up to see email

kbvwl3@w88y4bb17kt93yj.183 Sign up to see email
Megan Sniecinski

Chief Business Officer

yywzyy22b74@48t7j969wjq818q.1q2 Sign up to see email

2gt345l5qh1@72t2l0y7uz3104z.78h Sign up to see email
Steve Petrou

Co-Founder & Chief Scientific Officer

wk01vyq@874ghbb3j88hz6j.j59 Sign up to see email

zbzv2k9@63g0z466299l2z2.434 Sign up to see email
Tim Kelly

Chief Financial Officer

h1quz8@4hu0u2809gju3z0.3ww Sign up to see email

1vqw8g@vfgj68bq49g72w3.529 Sign up to see email

Praxis Precision Medicines Company Information

Praxis Precision Medicines, headquartered at 99 High Street, 30th Floor, Boston, Massachusetts, is dedicated to the development of precision therapies for central nervous system disorders. The company’s approach focuses on identifying therapeutic targets through human genetics and validating these targets and product candidates using translational tools. Praxis employs patient-guided development strategies and pursues efficient, rigorous clinical development paths to achieve proof-of-concept in humans. The company is involved in several clinical trials, including EMBOLD, EMBRAVE, and ESSENTIAL3, and offers an Expanded Access Policy that allows for the use of investigational drugs under certain conditions.

Report inaccurate information